October 17, 2014 by Brad Perriello
Venture capital investment in medical device companies rose both in terms of value and volume during the 3rd quarter, according to the MoneyTree report from PricewaterhouseCoopers and the National Venture Capital Assn., based on Thomson Reuters data.
Venture capital shops got behind medtech during the 3rd quarter, increasing their spend and the number of deals compared with the same period last year, according to the MoneyTree report from PricewaterhouseCoopers and the National Venture Capital Assn., based on Thomson Reuters data.
There were 78 medical device company deals worth $585.6 million during the quarter, according to the report, for increases of 18.2% and 13.3%, respectively. The average quarterly VC spend on medtech so far this year was also up, rising 15.1% to $624.0 million compared with Q3 2013.
And the overall VC spend in all industries this year has already surpassed the spend for all of last year, according to the MoneyTree report. There have been 3,154 deals worth a collective $33.17 billion during the 1st 3 quarters this year, compared with 4,134 deals worth $29.53 billion in 2013.
